Internal Medicine Journal最新文献

筛选
英文 中文
Improving detection of secondary immunodeficiency and vaccination after invasive airway infections: a prospective cohort study with retrospective comparison. 改进侵袭性气道感染后继发性免疫缺陷的检测和疫苗接种:一项回顾性比较的前瞻性队列研究。
IF 1.8 4区 医学
Internal Medicine Journal Pub Date : 2026-11-05 DOI: 10.1111/imj.70690
B Tan, M Metlapalli, M Liu, D Kotsanas, E L Smith, S Ojaimi
{"title":"Improving detection of secondary immunodeficiency and vaccination after invasive airway infections: a prospective cohort study with retrospective comparison.","authors":"B Tan, M Metlapalli, M Liu, D Kotsanas, E L Smith, S Ojaimi","doi":"10.1111/imj.70690","DOIUrl":"https://doi.org/10.1111/imj.70690","url":null,"abstract":"<p><strong>Background: </strong>Infections caused by encapsulated pathogens such as Streptococcus pneumoniae, Haemophilus influenzae and Neisseria meningitidis contribute to significant morbidity and mortality, with immunodeficiency being an important risk factor for recurrent and invasive disease. A previous retrospective Australian study identified a 6% rate of newly diagnosed immunodeficiency in such patients and highlighted inadequate screening.</p><p><strong>Methods: </strong>A prospective study at a large multi-centre health service in South-East Melbourne, Australia was conducted between June 2021 and September 2023. Adults (≥16 years) with the aforementioned organisms, isolated from sterile sites, were recruited. Participants underwent basic immunodeficiency testing and vaccinations. A retrospective cohort, comprising eligible but unenrolled patients over the same period, was retrospectively analysed for comparison.</p><p><strong>Results: </strong>Patients within the prospective cohort (n = 46) were compared with the retrospective cohort (n = 69), with the predominant organisms being S. pneumoniae (83%, 94/115), H. influenzae (13%, 15/115) and N. meningitidis (4%, 5/115). Vaccine-preventable strains accounted for 75% (55/73) of typed cases. A new diagnosis of immunodeficiency was identified more frequently in the prospective group (7/46, 15.2% vs 4/69, 5.8%, P = 0.1), with a numerically greater, though not statistically significant, increase in immunodeficiency detection rate seen in the prospective cohort (OR 2.9, 95% CI 0.7-14.3, P = 0.1). Post-illness vaccinations were more frequently recommended in the prospective group (OR 2.6, 95% CI 1.0-64, P = 0.03).</p><p><strong>Conclusion: </strong>Actively identifying patients with invasive airway pathogens and ensuring linkage with an infectious diseases service improves screening and diagnosis of immunodeficiencies and optimises vaccination opportunities.</p>","PeriodicalId":13625,"journal":{"name":"Internal Medicine Journal","volume":" ","pages":""},"PeriodicalIF":1.8,"publicationDate":"2026-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149333830","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Implementation of pharmacist-led chronic kidney disease screening in Australian community pharmacies: feasibility and characteristics of the screened population. 在澳大利亚社区药房实施药师主导的慢性肾脏疾病筛查:筛查人群的可行性和特点。
IF 1.8 4区 医学
Internal Medicine Journal Pub Date : 2026-11-02 DOI: 10.1111/imj.70692
Ayana Korsa, Ines Krass, Mimi Truong, Linda Do, Jing Xin Goh, Kamal Sud, David W Johnson, Sanjyot Vagholkar, Rita McMorrow, Lukas Kairaitis, Judy Mullan, Anh Tran, Connie Van, Wubshet Tesfaye, Natasa Gisev, Breonny Robson, Victoria Kim, Ronald L Castelino
{"title":"Implementation of pharmacist-led chronic kidney disease screening in Australian community pharmacies: feasibility and characteristics of the screened population.","authors":"Ayana Korsa, Ines Krass, Mimi Truong, Linda Do, Jing Xin Goh, Kamal Sud, David W Johnson, Sanjyot Vagholkar, Rita McMorrow, Lukas Kairaitis, Judy Mullan, Anh Tran, Connie Van, Wubshet Tesfaye, Natasa Gisev, Breonny Robson, Victoria Kim, Ronald L Castelino","doi":"10.1111/imj.70692","DOIUrl":"https://doi.org/10.1111/imj.70692","url":null,"abstract":"<p><strong>Background: </strong>The Chronic Kidney Disease Screening and Quality Use of Medicines trial aimed to improve chronic kidney disease (CKD) detection and optimise medication use in Australia. This analysis evaluates the feasibility of pharmacy-based screening for identifying individuals at risk of CKD and reports participant baseline characteristics.</p><p><strong>Methods: </strong>Eligible participants for the trial were aged 35-74 years and had ≥1 CKD risk factor. The intervention group received a QKidney® risk assessment, point-of-care test (POCT) and medication reviews, while the control group received the risk assessment only. QKidney® scores and blood pressure (BP) classified 5-year CKD risk as low, moderate or high. Intervention participants at moderate-to-high risk underwent POCT of serum creatinine to estimate estimated glomerular filtration rate (eGFR). Reduced kidney function was defined as eGFR < 60 mL/min/1.73 m<sup>2</sup> and prevalence was compared with Australian National Health Measures Survey 2022-2024 estimates. Data were analysed in Statistical Package for Social Sciences (version 31) using descriptive statistics.</p><p><strong>Results: </strong>Of the 1486 participants recruited between March 2023 and December 2024, 1189 were included in this analysis (550 (46%) intervention, 639 (54%) control). Risk assessment was completed in 99.9% of participants using QKidney® and in 100% using BP. A POCT was performed for 84% of intervention participants at moderate to high risk. Of those fulfilling pre-defined general practice referral criteria, 73% were referred. Overall, 68% of trial participants were at moderate to high CKD risk (59% identified by QKidney® and 30% by BP). Additionally, 21% had reduced kidney function based on POCT results - substantially higher than the national estimates (5.2%).</p><p><strong>Conclusions: </strong>Pharmacy-based targeted screening was feasible for identifying individuals at risk of developing CKD and could strengthen early detection efforts in Australia.</p>","PeriodicalId":13625,"journal":{"name":"Internal Medicine Journal","volume":" ","pages":""},"PeriodicalIF":1.8,"publicationDate":"2026-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149320864","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Defining best practice for very old patients following unplanned intensive care admission: protocol of the Delphi consensus study. 确定高龄患者在非计划重症监护入院后的最佳实践:德尔菲共识研究的协议。
IF 1.8 4区 医学
Internal Medicine Journal Pub Date : 2026-10-31 DOI: 10.1111/imj.70687
Ashwin Subramaniam, Ryan Ruiyang Ling, Sumeet Rai, Rachael Lim, Sanjiv Vij, Velandai Srikanth, Daryl Jones, Imogen Mitchell, Melissa J Bloomer, Rand Butcher, Krish Sundararajan, Deb Sharp, Thomas Rollinson, Alex Psirides, Sushma Ashwin, Justin Oakley, Emma McCahon, Michael Beil, Christian Jung, Susannah Leaver, Hans Flaatten, Kollengode Ramanathan, Manoj Saxena, Michael Bailey, David Pilcher
{"title":"Defining best practice for very old patients following unplanned intensive care admission: protocol of the Delphi consensus study.","authors":"Ashwin Subramaniam, Ryan Ruiyang Ling, Sumeet Rai, Rachael Lim, Sanjiv Vij, Velandai Srikanth, Daryl Jones, Imogen Mitchell, Melissa J Bloomer, Rand Butcher, Krish Sundararajan, Deb Sharp, Thomas Rollinson, Alex Psirides, Sushma Ashwin, Justin Oakley, Emma McCahon, Michael Beil, Christian Jung, Susannah Leaver, Hans Flaatten, Kollengode Ramanathan, Manoj Saxena, Michael Bailey, David Pilcher","doi":"10.1111/imj.70687","DOIUrl":"https://doi.org/10.1111/imj.70687","url":null,"abstract":"<p><strong>Background: </strong>Very old patients (≥80 years) represent a rapidly increasing proportion of intensive care unit (ICU) admissions across Australia and New Zealand. Care of this population is characterised by substantial prognostic uncertainty and variability in ICU triage, treatment limitation and post-ICU pathways. In particular, the role and implementation of time-limited ICU trials remain inconsistent.</p><p><strong>Aims: </strong>To establish multidisciplinary consensus on best-practice management of very old patients following unplanned ICU admission in Australia and New Zealand, including the role, structure and implementation of time-limited ICU trials.</p><p><strong>Methods: </strong>We will conduct a modified, multiround Delphi consensus study. A multidisciplinary, multispecialty panel of expert clinicians (intensive care, geriatrics, emergency medicine), doctors in training, nurses, allied health professionals, ethicists and health service leaders across Australia and New Zealand will be recruited through purposive and snowball sampling. Participants will rate statements using the Likert scale across multiple rounds. Anonymised aggregated feedback will be provided to participants between rounds to facilitate convergence of opinion. Consensus will be defined a priori using predefined thresholds and median scores. Quantitative analyses will include descriptive statistics and exploratory subgroup comparisons, while free-text responses will undergo thematic analysis.</p><p><strong>Results: </strong>The primary outcome is to establish multidisciplinary consensus on best-practice management of very old patients following unplanned ICU admission, including the role and implementation of time-limited ICU trials. Secondary outcomes include identifying areas of agreement and variation across groups and convergence across Delphi rounds. A tertiary outcome is to explore barriers and facilitators to implementation to inform a structured decision-making framework.</p><p><strong>Conclusions: </strong>This study will generate consensus-based recommendations and a structured framework for the use of time-limited ICU trials in Australia and New Zealand ICUs. By addressing current practice variability, it aims to support transparent, patient-centred decision-making and inform future research and policy in the care of very old critically ill patients.</p>","PeriodicalId":13625,"journal":{"name":"Internal Medicine Journal","volume":" ","pages":""},"PeriodicalIF":1.8,"publicationDate":"2026-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149320862","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical utility of bronchoalveolar lavage in immunocompromised patients with pulmonary infiltrates: impact on diagnostic yield and management. 支气管肺泡灌洗在肺浸润性免疫功能低下患者中的临床应用:对诊断率和处理的影响。
IF 1.8 4区 医学
Internal Medicine Journal Pub Date : 2026-10-31 DOI: 10.1111/imj.70689
Hanson Siu, Ajit Nair, Gayan Kathriachchige, Erica Subhas, Darren Mansfield
{"title":"Clinical utility of bronchoalveolar lavage in immunocompromised patients with pulmonary infiltrates: impact on diagnostic yield and management.","authors":"Hanson Siu, Ajit Nair, Gayan Kathriachchige, Erica Subhas, Darren Mansfield","doi":"10.1111/imj.70689","DOIUrl":"https://doi.org/10.1111/imj.70689","url":null,"abstract":"<p><strong>Background: </strong>Pulmonary infiltrates in immunocompromised patients are associated with high morbidity and mortality, and accurate diagnosis is often challenging due to overlapping infectious and non-infectious aetiologies. Flexible bronchoscopy with bronchoalveolar lavage (BAL) is widely used, but its contemporary real-world clinical utility across heterogeneous immunocompromised populations remains uncertain.</p><p><strong>Aims: </strong>To retrospectively evaluate the clinical utility of inpatient flexible bronchoscopy with BAL in immunocompromised adults presenting with new pulmonary infiltrates at a tertiary referral centre.</p><p><strong>Methods: </strong>Retrospective cohort study conducted at a Victorian tertiary centre including immunocompromised adults who underwent inpatient flexible bronchoscopy for new CT-confirmed pulmonary infiltrates between January 2022 and December 2024. The primary outcomes were diagnostic yield and the proportion of procedures resulting in a change in clinical management.</p><p><strong>Results: </strong>Sixty-two patients were included (mean age 60.3 ± 16.9 years; 38.7% female). Patients with underlying haematological malignancy accounted for 59.7% of cases, and 83.9% were receiving empiric antibiotic therapy prior to bronchoscopy. Overall diagnostic yield was 43.5% (27/62). Bronchoscopy resulted in a change in clinical management in 64.5% of cases (40/62), most commonly initiation of targeted antimicrobial therapy (47.5%). The median interval from imaging to bronchoscopy was 4.5 days. Procedural complications were uncommon and limited (4.8%). Patients with haematological malignancy had higher odds of fungal infection (OR 6.81, 95% CI 1.33-68.54; P = 0.009) and mortality at 12 months (51.4% vs 20.0%; OR 4.22, CI 1.17-17.16, P = 0.017) compared to non-haematological causes of immunocompromise.</p><p><strong>Conclusion: </strong>In immunocompromised inpatients with pulmonary infiltrates, bronchoscopy with BAL was associated with frequent changes in clinical management and a low rate of procedure-related complications. These observational findings support its use in appropriately selected patients, while prospective studies are needed to determine its effect on patient-centred outcomes.</p>","PeriodicalId":13625,"journal":{"name":"Internal Medicine Journal","volume":" ","pages":""},"PeriodicalIF":1.8,"publicationDate":"2026-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149320861","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
How should junior doctors navigate artificial intelligence clinical advice? 初级医生应该如何驾驭人工智能临床建议?
IF 1.8 4区 医学
Internal Medicine Journal Pub Date : 2026-10-31 DOI: 10.1111/imj.70662
Max Drezga-Kleiminger, Laura Gilbertson
{"title":"How should junior doctors navigate artificial intelligence clinical advice?","authors":"Max Drezga-Kleiminger, Laura Gilbertson","doi":"10.1111/imj.70662","DOIUrl":"https://doi.org/10.1111/imj.70662","url":null,"abstract":"<p><p>Artificial intelligence (AI) clinical decision support tools are becoming increasingly integrated into medical decision-making, offering rapid, evidence-based clinical recommendations. While surrounding discussion has largely focussed on senior clinicians, junior doctors, responsible for many day-to-day decisions in hospitals, face unique challenges in navigating these technologies among the many existing information sources. This paper examines the epistemic, ethical and practical implications of AI use by junior doctors, highlighting its potential to streamline knowledge access, as well as risks including automation, bias and deskilling. We introduce a suggested framework to help junior doctors navigate AI clinical advice and integrate it safely into clinical practice, among other information sources.</p>","PeriodicalId":13625,"journal":{"name":"Internal Medicine Journal","volume":" ","pages":""},"PeriodicalIF":1.8,"publicationDate":"2026-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149320863","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Late diagnosis in adults with inborn errors of immunity: the hypomorphic phenotype deserves explicit recognition. 成人先天性免疫缺陷的晚期诊断:畸形表型值得明确认识。
IF 1.8 4区 医学
Internal Medicine Journal Pub Date : 2026-10-31 DOI: 10.1111/imj.70691
Nezihe Köker Özer, Ercan Yılmaz, Erdem Topal
{"title":"Late diagnosis in adults with inborn errors of immunity: the hypomorphic phenotype deserves explicit recognition.","authors":"Nezihe Köker Özer, Ercan Yılmaz, Erdem Topal","doi":"10.1111/imj.70691","DOIUrl":"https://doi.org/10.1111/imj.70691","url":null,"abstract":"","PeriodicalId":13625,"journal":{"name":"Internal Medicine Journal","volume":" ","pages":""},"PeriodicalIF":1.8,"publicationDate":"2026-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149320865","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Australian Standards of Care for Genetic and Genomic Testing in Kidney Disease, Chapter 4 澳大利亚肾脏疾病遗传和基因组检测护理标准,第4章。
IF 1.8 4区 医学
Internal Medicine Journal Pub Date : 2026-10-30 DOI: 10.1111/imj.70673
Sadia Jahan, Julia Jefferis, Jacqueline Soraru, Chirag Patel, Erik Biros, Trudie Harris, Kushani Jayasinghe, Amali Mallawaarachchi, Zornitza Stark, Andrew J. Mallett, the KidGen Guidelines Working Group
{"title":"Australian Standards of Care for Genetic and Genomic Testing in Kidney Disease, Chapter 4","authors":"Sadia Jahan,&nbsp;Julia Jefferis,&nbsp;Jacqueline Soraru,&nbsp;Chirag Patel,&nbsp;Erik Biros,&nbsp;Trudie Harris,&nbsp;Kushani Jayasinghe,&nbsp;Amali Mallawaarachchi,&nbsp;Zornitza Stark,&nbsp;Andrew J. Mallett,&nbsp;the KidGen Guidelines Working Group","doi":"10.1111/imj.70673","DOIUrl":"10.1111/imj.70673","url":null,"abstract":"","PeriodicalId":13625,"journal":{"name":"Internal Medicine Journal","volume":"56 S5","pages":"15-17"},"PeriodicalIF":1.8,"publicationDate":"2026-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/imj.70673","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149297235","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Australian Standards of Care for Genetic and Genomic Testing in Kidney Disease, Chapter 2 澳大利亚肾脏疾病遗传和基因组检测护理标准,第2章。
IF 1.8 4区 医学
Internal Medicine Journal Pub Date : 2026-10-30 DOI: 10.1111/imj.70671
Sadia Jahan, Julia Jefferis, Jacqueline Soraru, Chirag Patel, Erik Biros, Trudie Harris, Kushani Jayasinghe, Amali Mallawaarachchi, Zornitza Stark, Andrew J. Mallett, the KidGen Guidelines Working Group
{"title":"Australian Standards of Care for Genetic and Genomic Testing in Kidney Disease, Chapter 2","authors":"Sadia Jahan,&nbsp;Julia Jefferis,&nbsp;Jacqueline Soraru,&nbsp;Chirag Patel,&nbsp;Erik Biros,&nbsp;Trudie Harris,&nbsp;Kushani Jayasinghe,&nbsp;Amali Mallawaarachchi,&nbsp;Zornitza Stark,&nbsp;Andrew J. Mallett,&nbsp;the KidGen Guidelines Working Group","doi":"10.1111/imj.70671","DOIUrl":"10.1111/imj.70671","url":null,"abstract":"","PeriodicalId":13625,"journal":{"name":"Internal Medicine Journal","volume":"56 S5","pages":"10-12"},"PeriodicalIF":1.8,"publicationDate":"2026-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/imj.70671","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149297175","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Glossary and Abbreviations 词汇和缩略语
IF 1.8 4区 医学
Internal Medicine Journal Pub Date : 2026-10-30 DOI: 10.1111/imj.70705
{"title":"Glossary and Abbreviations","authors":"","doi":"10.1111/imj.70705","DOIUrl":"https://doi.org/10.1111/imj.70705","url":null,"abstract":"","PeriodicalId":13625,"journal":{"name":"Internal Medicine Journal","volume":"56 S5","pages":""},"PeriodicalIF":1.8,"publicationDate":"2026-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149311086","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Australian Standards of Care for Genetic and Genomic Testing in Kidney Disease, Chapter 9 澳大利亚肾脏疾病遗传和基因组检测护理标准,第9章。
IF 1.8 4区 医学
Internal Medicine Journal Pub Date : 2026-10-30 DOI: 10.1111/imj.70678
Sadia Jahan, Julia Jefferis, Jacqueline Soraru, Chirag Patel, Erik Biros, Trudie Harris, Kushani Jayasinghe, Amali Mallawaarachchi, Zornitza Stark, Andrew J. Mallett, the KidGen Guidelines Working Group
{"title":"Australian Standards of Care for Genetic and Genomic Testing in Kidney Disease, Chapter 9","authors":"Sadia Jahan,&nbsp;Julia Jefferis,&nbsp;Jacqueline Soraru,&nbsp;Chirag Patel,&nbsp;Erik Biros,&nbsp;Trudie Harris,&nbsp;Kushani Jayasinghe,&nbsp;Amali Mallawaarachchi,&nbsp;Zornitza Stark,&nbsp;Andrew J. Mallett,&nbsp;the KidGen Guidelines Working Group","doi":"10.1111/imj.70678","DOIUrl":"10.1111/imj.70678","url":null,"abstract":"","PeriodicalId":13625,"journal":{"name":"Internal Medicine Journal","volume":"56 S5","pages":"28-30"},"PeriodicalIF":1.8,"publicationDate":"2026-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/imj.70678","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149297156","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书